Sahakyan, Y. (2022) “Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia: A Canadian healthcare payer perspective”, Canadian Urological Association Journal, 17(4), pp. 103–10. doi: 10.5489/cuaj.8045.